News
3d
MedPage Today on MSNNovel Lupus Drug Clears Phase II HurdleCalled enpatoran, the agent targets the Toll-like receptor (TLR) species 7 and 8. Some 50%-60% of patients with systemic ...
Revolutionary advancements in blood cancer treatment, from targeted therapy to gene editing, promise more effective and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results